New clinical study – Novaliq NovaTears(R)+Omega-3 eye drops

NovaTears(R)+Omega-3, an innovative dry eye treatment in-licensed and distributed in Australia and New Zealand by AFT Pharmaceuticals, is a significantly effective treatment for evaporative Dry Eye Disease (DED), a new clinical study1 has found. Please see the attached announcement for more information. End CA:00376371 For:AFT Type:GENERAL Time:2021-07-29 08:56:24